Hamilton-Craig Ian
Reparation General Hospital, Adelaide, South Australia, Australia.
Semin Vasc Med. 2004 Feb;4(1):87-92. doi: 10.1055/s-2004-822990.
It is estimated that in the Asia-Pacific region, more than 5.2 million persons are suffering from familial hypercholesterolemia (FH). This means that more than half of the estimated world total of 10 million FH patients are living in this part of the world, of which the vast majority is not aware of their dangerous condition, let alone being adequately treated. Obviously, an intensive case-finding program to identify patients and subsequent clinical management are required to prevent premature cardiovascular disease and death caused by the consequences of inherited hypercholesterolemia. This article describes the current situation concerning FH and the initiatives and actions undertaken in Australia to contribute to actively identifying patients with FH in that country.
据估计,在亚太地区,超过520万人患有家族性高胆固醇血症(FH)。这意味着,全球估计1000万FH患者中,超过一半生活在该地区,其中绝大多数人并未意识到自己的危险状况,更不用说得到充分治疗了。显然,需要开展强化病例发现计划以识别患者,并进行后续临床管理,以预防由遗传性高胆固醇血症后果导致的心血管疾病过早发生和死亡。本文描述了FH的现状以及澳大利亚为积极识别该国FH患者所采取的举措和行动。